Naoko Wada
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy-naive advanced melanoma.
Journal: The Journal of dermatology
Published: May 15, 2020
Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma.
Journal: Frontiers in medicine
Published: February 17, 2019
A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma.
Journal: The American journal of case reports
Published: January 26, 2019
Trichophytic closure for cicatricial alopecia on the scalp.
Journal: The Journal of dermatology
Published: January 08, 2019
Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 19, 2018
Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.
Journal: Frontiers in oncology
Published: June 30, 2018
Melanoma and Immune Checkpoint Inhibitors.
Journal: Current oncology reports
Published: March 24, 2018
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
Journal: Cancer science
Published: February 22, 2018
Case of deep vein thrombosis in a patient with advanced malignant melanoma treated with dabrafenib and trametinib.
Journal: The Journal of dermatology
Published: February 13, 2018
Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma.
Journal: BMC endocrine disorders
Published: August 26, 2017
Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
Journal: The Journal of dermatology
Published: July 06, 2017
Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma.
Journal: The Journal of dermatology
Published: April 10, 2017
Last Updated: 09/26/2026